Trials / Terminated
TerminatedNCT03254160
DNS-3379 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 42-Day Treatment Study to Evaluate the Effect of DNS-3379 on Upper Extremity Motor Function Following Ischemic Stroke
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Dart NeuroScience, LLC · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, double-blind, placebo-controlled parallel group outpatient 42-day treatment study that will utilize standard stroke rehabilitation outcome measures to evaluate the effect of DNS-3379 on upper extremity motor recovery in subjects following ischemic stroke.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DNS-3379 | DNS-3379 |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2017-11-13
- Primary completion
- 2017-12-31
- Completion
- 2017-12-31
- First posted
- 2017-08-18
- Last updated
- 2018-02-01
Locations
16 sites across 2 countries: Australia, New Zealand
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03254160. Inclusion in this directory is not an endorsement.